Evidence map›Paper›PMID 38510028›Full record

ArticleHeliyon2024

Surface activation of Hastalex by vacuum argon plasma for cytocompatibility enhancement.

Nikola Slepičková Kasálková, Silvie Rimpelová, Cyril Vacek, Dominik Fajstavr, Václav Švorčík, Petr Sajdl, Petr Slepička

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nikola Slepičková KasálkováDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Silvie RimpelováDepartment of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Cyril VacekDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Dominik FajstavrDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Václav ŠvorčíkDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Petr SajdlDepartment of Power Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.
Petr SlepičkaDepartment of Solid State Engineering, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we present surface analysis and biocompatibility evaluation of novel composite material based on graphene oxide traded as Hastalex. First, the surface morphology and elemental analysis of the pristine material were examined by atomic force and scanning electron microscopies, and by energy-dispersive and X-ray photoelectron spectroscopies, respectively. The Hastalex surface was then modified by plasma (3 and 8 W with exposure times up to 240 s), the impact of which on the material surface wettability and morphology was further evaluated. In addition, the material aging was studied at room and elevated temperatures. Significant changes in surface roughness, morphology, and area were detected at the nanometer scale after plasma exposure. An increase in oxygen content due to the plasma exposure was observed both for 3 and 8 W. The plasma treatment had an outstanding effect on the cytocompatibility of Hastalex foil treated at both input powers of 3 and 8 W. The cell number of human MRC-5 fibroblasts on Hastalex foils exposed to plasma increased significantly compared to pristine Hastalex and even to tissue culture polystyrene. The plasma exposure also affected the fibroblasts' cell growth and shape.

Indexed as

Carbon compositeCytocompatibilityMorphologyNanostructurePatternPolymer stabilitySurface chemistrySurface modification

Identifiers

PMID38510028
PMCPMC10951612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.